Cargando…

A prospective evaluation of AI-augmented epidemiology to forecast COVID-19 in the USA and Japan

The COVID-19 pandemic has highlighted the global need for reliable models of disease spread. We propose an AI-augmented forecast modeling framework that provides daily predictions of the expected number of confirmed COVID-19 deaths, cases, and hospitalizations during the following 4 weeks. We presen...

Descripción completa

Detalles Bibliográficos
Autores principales: Arık, Sercan Ö., Shor, Joel, Sinha, Rajarishi, Yoon, Jinsung, Ledsam, Joseph R., Le, Long T., Dusenberry, Michael W., Yoder, Nathanael C., Popendorf, Kris, Epshteyn, Arkady, Euphrosine, Johan, Kanal, Elli, Jones, Isaac, Li, Chun-Liang, Luan, Beth, Mckenna, Joe, Menon, Vikas, Singh, Shashank, Sun, Mimi, Ravi, Ashwin Sura, Zhang, Leyou, Sava, Dario, Cunningham, Kane, Kayama, Hiroki, Tsai, Thomas, Yoneoka, Daisuke, Nomura, Shuhei, Miyata, Hiroaki, Pfister, Tomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8501040/
https://www.ncbi.nlm.nih.gov/pubmed/34625656
http://dx.doi.org/10.1038/s41746-021-00511-7
_version_ 1784580566961618944
author Arık, Sercan Ö.
Shor, Joel
Sinha, Rajarishi
Yoon, Jinsung
Ledsam, Joseph R.
Le, Long T.
Dusenberry, Michael W.
Yoder, Nathanael C.
Popendorf, Kris
Epshteyn, Arkady
Euphrosine, Johan
Kanal, Elli
Jones, Isaac
Li, Chun-Liang
Luan, Beth
Mckenna, Joe
Menon, Vikas
Singh, Shashank
Sun, Mimi
Ravi, Ashwin Sura
Zhang, Leyou
Sava, Dario
Cunningham, Kane
Kayama, Hiroki
Tsai, Thomas
Yoneoka, Daisuke
Nomura, Shuhei
Miyata, Hiroaki
Pfister, Tomas
author_facet Arık, Sercan Ö.
Shor, Joel
Sinha, Rajarishi
Yoon, Jinsung
Ledsam, Joseph R.
Le, Long T.
Dusenberry, Michael W.
Yoder, Nathanael C.
Popendorf, Kris
Epshteyn, Arkady
Euphrosine, Johan
Kanal, Elli
Jones, Isaac
Li, Chun-Liang
Luan, Beth
Mckenna, Joe
Menon, Vikas
Singh, Shashank
Sun, Mimi
Ravi, Ashwin Sura
Zhang, Leyou
Sava, Dario
Cunningham, Kane
Kayama, Hiroki
Tsai, Thomas
Yoneoka, Daisuke
Nomura, Shuhei
Miyata, Hiroaki
Pfister, Tomas
author_sort Arık, Sercan Ö.
collection PubMed
description The COVID-19 pandemic has highlighted the global need for reliable models of disease spread. We propose an AI-augmented forecast modeling framework that provides daily predictions of the expected number of confirmed COVID-19 deaths, cases, and hospitalizations during the following 4 weeks. We present an international, prospective evaluation of our models’ performance across all states and counties in the USA and prefectures in Japan. Nationally, incident mean absolute percentage error (MAPE) for predicting COVID-19 associated deaths during prospective deployment remained consistently <8% (US) and <29% (Japan), while cumulative MAPE remained <2% (US) and <10% (Japan). We show that our models perform well even during periods of considerable change in population behavior, and are robust to demographic differences across different geographic locations. We further demonstrate that our framework provides meaningful explanatory insights with the models accurately adapting to local and national policy interventions. Our framework enables counterfactual simulations, which indicate continuing Non-Pharmaceutical Interventions alongside vaccinations is essential for faster recovery from the pandemic, delaying the application of interventions has a detrimental effect, and allow exploration of the consequences of different vaccination strategies. The COVID-19 pandemic remains a global emergency. In the face of substantial challenges ahead, the approach presented here has the potential to inform critical decisions.
format Online
Article
Text
id pubmed-8501040
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-85010402021-10-22 A prospective evaluation of AI-augmented epidemiology to forecast COVID-19 in the USA and Japan Arık, Sercan Ö. Shor, Joel Sinha, Rajarishi Yoon, Jinsung Ledsam, Joseph R. Le, Long T. Dusenberry, Michael W. Yoder, Nathanael C. Popendorf, Kris Epshteyn, Arkady Euphrosine, Johan Kanal, Elli Jones, Isaac Li, Chun-Liang Luan, Beth Mckenna, Joe Menon, Vikas Singh, Shashank Sun, Mimi Ravi, Ashwin Sura Zhang, Leyou Sava, Dario Cunningham, Kane Kayama, Hiroki Tsai, Thomas Yoneoka, Daisuke Nomura, Shuhei Miyata, Hiroaki Pfister, Tomas NPJ Digit Med Article The COVID-19 pandemic has highlighted the global need for reliable models of disease spread. We propose an AI-augmented forecast modeling framework that provides daily predictions of the expected number of confirmed COVID-19 deaths, cases, and hospitalizations during the following 4 weeks. We present an international, prospective evaluation of our models’ performance across all states and counties in the USA and prefectures in Japan. Nationally, incident mean absolute percentage error (MAPE) for predicting COVID-19 associated deaths during prospective deployment remained consistently <8% (US) and <29% (Japan), while cumulative MAPE remained <2% (US) and <10% (Japan). We show that our models perform well even during periods of considerable change in population behavior, and are robust to demographic differences across different geographic locations. We further demonstrate that our framework provides meaningful explanatory insights with the models accurately adapting to local and national policy interventions. Our framework enables counterfactual simulations, which indicate continuing Non-Pharmaceutical Interventions alongside vaccinations is essential for faster recovery from the pandemic, delaying the application of interventions has a detrimental effect, and allow exploration of the consequences of different vaccination strategies. The COVID-19 pandemic remains a global emergency. In the face of substantial challenges ahead, the approach presented here has the potential to inform critical decisions. Nature Publishing Group UK 2021-10-08 /pmc/articles/PMC8501040/ /pubmed/34625656 http://dx.doi.org/10.1038/s41746-021-00511-7 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Arık, Sercan Ö.
Shor, Joel
Sinha, Rajarishi
Yoon, Jinsung
Ledsam, Joseph R.
Le, Long T.
Dusenberry, Michael W.
Yoder, Nathanael C.
Popendorf, Kris
Epshteyn, Arkady
Euphrosine, Johan
Kanal, Elli
Jones, Isaac
Li, Chun-Liang
Luan, Beth
Mckenna, Joe
Menon, Vikas
Singh, Shashank
Sun, Mimi
Ravi, Ashwin Sura
Zhang, Leyou
Sava, Dario
Cunningham, Kane
Kayama, Hiroki
Tsai, Thomas
Yoneoka, Daisuke
Nomura, Shuhei
Miyata, Hiroaki
Pfister, Tomas
A prospective evaluation of AI-augmented epidemiology to forecast COVID-19 in the USA and Japan
title A prospective evaluation of AI-augmented epidemiology to forecast COVID-19 in the USA and Japan
title_full A prospective evaluation of AI-augmented epidemiology to forecast COVID-19 in the USA and Japan
title_fullStr A prospective evaluation of AI-augmented epidemiology to forecast COVID-19 in the USA and Japan
title_full_unstemmed A prospective evaluation of AI-augmented epidemiology to forecast COVID-19 in the USA and Japan
title_short A prospective evaluation of AI-augmented epidemiology to forecast COVID-19 in the USA and Japan
title_sort prospective evaluation of ai-augmented epidemiology to forecast covid-19 in the usa and japan
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8501040/
https://www.ncbi.nlm.nih.gov/pubmed/34625656
http://dx.doi.org/10.1038/s41746-021-00511-7
work_keys_str_mv AT arıksercano aprospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan
AT shorjoel aprospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan
AT sinharajarishi aprospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan
AT yoonjinsung aprospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan
AT ledsamjosephr aprospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan
AT lelongt aprospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan
AT dusenberrymichaelw aprospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan
AT yodernathanaelc aprospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan
AT popendorfkris aprospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan
AT epshteynarkady aprospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan
AT euphrosinejohan aprospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan
AT kanalelli aprospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan
AT jonesisaac aprospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan
AT lichunliang aprospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan
AT luanbeth aprospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan
AT mckennajoe aprospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan
AT menonvikas aprospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan
AT singhshashank aprospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan
AT sunmimi aprospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan
AT raviashwinsura aprospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan
AT zhangleyou aprospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan
AT savadario aprospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan
AT cunninghamkane aprospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan
AT kayamahiroki aprospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan
AT tsaithomas aprospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan
AT yoneokadaisuke aprospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan
AT nomurashuhei aprospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan
AT miyatahiroaki aprospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan
AT pfistertomas aprospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan
AT arıksercano prospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan
AT shorjoel prospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan
AT sinharajarishi prospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan
AT yoonjinsung prospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan
AT ledsamjosephr prospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan
AT lelongt prospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan
AT dusenberrymichaelw prospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan
AT yodernathanaelc prospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan
AT popendorfkris prospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan
AT epshteynarkady prospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan
AT euphrosinejohan prospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan
AT kanalelli prospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan
AT jonesisaac prospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan
AT lichunliang prospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan
AT luanbeth prospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan
AT mckennajoe prospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan
AT menonvikas prospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan
AT singhshashank prospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan
AT sunmimi prospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan
AT raviashwinsura prospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan
AT zhangleyou prospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan
AT savadario prospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan
AT cunninghamkane prospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan
AT kayamahiroki prospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan
AT tsaithomas prospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan
AT yoneokadaisuke prospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan
AT nomurashuhei prospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan
AT miyatahiroaki prospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan
AT pfistertomas prospectiveevaluationofaiaugmentedepidemiologytoforecastcovid19intheusaandjapan